Rchr
J-GLOBAL ID:200901077237951523   Update date: Jan. 31, 2024

Akizawa Tadao

アキザワ タダオ | Akizawa Tadao
Affiliation and department:
Job title: Professor
Research field  (1): Nephrology
Research keywords  (6): 代謝性骨疾患 ,  血液浄化医学 ,  腎臓内科学 ,  Metabolic Bone Disease ,  Blood Purification ,  Nephrology
Research theme for competitive and other funds  (17):
  • 2008 - 2010 Experimental study for the regression of chronic kidney disease and mineral bone disorder(CKD-MBD)
  • 2006 - 2007 Cross talk between the onset of renal osteodystrophy and ectopic vascular calcification
  • 2004 - 2005 Effect of renal hyperparathyroidism on the vascular calcification in uremic rats.
  • 2003 - 2004 THE ANALYSIS OF ADENOVO GENE IS EXPRESSED WITH SECONDARY HYPERPARATHYROIDISM
  • 2002 - 2003 Pathogenesis and control of renal osteodystrophy
Show all
Papers (536):
  • Masaaki Nakayama, Shuhei Kobayashi, Miho Kusakabe, Meiko Ohara, Kaoru Nakanishi, Tadao Akizawa, Masafumi Fukagawa. Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial. Clinical and experimental nephrology. 2023
  • Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa. Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PLOS ONE. 2022. 17. 12. e0279078-e0279078
  • Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Akiko Takeshima, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida. Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2022
  • Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida. Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study. Clinical and experimental nephrology. 2022
  • Hiroaki Ogata, Masafumi Fukagawa, Hideki Hirakata, Tatsuo Kagimura, Tadao Akizawa. Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial. Clinical and experimental nephrology. 2022
more...
MISC (202):
  • 峰島 三千男, 友 雅司, 中元 秀友, 宍戸 寛治, 秋澤 忠男, 内野 順司, 本間 崇, 日本透析医学会学術委員会透析排水管理ワーキンググループ. 透析排水管理に必要な除害施設の導入 東京都23区内を例として. 日本臨床工学技士会会誌. 2021. 73. 12-14
  • 峰島 三千男, 友 雅司, 中元 秀友, 宍戸 寛治, 秋澤 忠男, 内野 順司, 本間 崇, 日本透析医学会学術委員会透析排水管理ワーキンググループ. 透析排水管理に必要な除害施設の導入 東京都23区内を例として. 日本透析医学会雑誌. 2021. 54. 3. 119-122
  • Hiroyasu Yamamoto, Megumi Taguchi, Kiyoshi Nobori, Yoshimi Matsuda, Kazuma Iekushi, Tadao Akizawa. TO INVESTIGATE THE EFFICACY AND SAFETY OF MOLIDUSTAT IN NON-DIALYSIS PATIENTS WITH RENAL ANEMIA WHO ARE NOT TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS: MIYABI ND-C. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020. 35. 2177-2177
  • Tadao Akizawa, Kazuaki Ikejiri, Yuichiro Kondo, Yuichi Endo, Masafumi Fukagawa. Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism. Therapeutic Apheresis and Dialysis. 2020. 24. 3. 248-257
  • 峰島 三千男, 友 雅司, 中元 秀友, 宍戸 寛治, 秋澤 忠男, 内野 順司, 本間 崇, 日本透析医学会学術委員会透析排液管理ワーキンググループ. 2019年版 透析排水基準. 日本臨床工学技士会会誌. 2020. 68. 31-33
more...
Books (10):
  • 服薬指導 Q and A 腎臓病編
    医薬ジャーナル社 2003
  • 急性血液浄化療法マニュアル
    南江堂 2002
  • 透析療法ネクストII
    医学図書出版 2002
  • 透析患者の検査値の読み方
    日本メディカルセンター 2002
  • 透析療法のリスクマネジメント
    中外医学社 2002
more...
Professional career (1):
  • (BLANK)
Committee career (2):
  • 日本透析医会 会長
  • 国際アフェレシス学会 理事
Association Membership(s) (7):
国際血液浄化学会 ,  日本透析医学会 ,  日本急性血液浄化学会 ,  日本人工臓器学会 ,  日本腎臓学会 ,  国際アフェレシス学会 ,  日本アフェレシス学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page